Corrigendum to "ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance" [Blood Cells Mol. Dis. 53, (1-2), (June-August 2014) 47-55], doi:10.1016/j.bcmd.2014.02.008

A. F. Ferreira; L. G. Moura; I. Tojal; L. Ambrósio; B. Pinto-Simões; N. Hamerschlak; G. A. Calin; C. Ivan; D. T. Covas; S. Kashima; F. A. Castro

doi:10.1016/j.bcmd.2015.08.005

Corrigendum to "ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance" [Blood Cells Mol. Dis. 53, (1-2), (June-August 2014) 47-55], doi:10.1016/j.bcmd.2014.02.008

A. F. Ferreira, L. G. Moura, I. Tojal, L. Ambrósio, B. Pinto-Simões, N. Hamerschlak, G. A. Calin, C. Ivan, D. T. Covas, S. Kashima, F. A. Castro

Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	420
Number of pages	1
Journal	Blood Cells, Molecules, and Diseases
Volume	55
Issue number	4
DOIs	https://doi.org/10.1016/j.bcmd.2015.08.005
State	Published - Dec 2015

ASJC Scopus subject areas

Molecular Medicine
Molecular Biology
Hematology
Cell Biology

Access to Document

10.1016/j.bcmd.2015.08.005

Cite this

Ferreira, A. F., Moura, L. G., Tojal, I., Ambrósio, L., Pinto-Simões, B., Hamerschlak, N., Calin, G. A., Ivan, C., Covas, D. T., Kashima, S., & Castro, F. A. (2015). Corrigendum to "ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance" [Blood Cells Mol. Dis. 53, (1-2), (June-August 2014) 47-55], doi:10.1016/j.bcmd.2014.02.008. Blood Cells, Molecules, and Diseases, 55(4), 420. https://doi.org/10.1016/j.bcmd.2015.08.005

Corrigendum to "ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance" [Blood Cells Mol. Dis. 53, (1-2), (June-August 2014) 47-55], doi:10.1016/j.bcmd.2014.02.008. / Ferreira, A. F.; Moura, L. G.; Tojal, I. et al.
In: Blood Cells, Molecules, and Diseases, Vol. 55, No. 4, 12.2015, p. 420.

Research output: Contribution to journal › Comment/debate › peer-review

Ferreira, AF, Moura, LG, Tojal, I, Ambrósio, L, Pinto-Simões, B, Hamerschlak, N, Calin, GA, Ivan, C, Covas, DT, Kashima, S & Castro, FA 2015, 'Corrigendum to "ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance" [Blood Cells Mol. Dis. 53, (1-2), (June-August 2014) 47-55], doi:10.1016/j.bcmd.2014.02.008', Blood Cells, Molecules, and Diseases, vol. 55, no. 4, pp. 420. https://doi.org/10.1016/j.bcmd.2015.08.005

Ferreira AF, Moura LG, Tojal I, Ambrósio L, Pinto-Simões B, Hamerschlak N et al. Corrigendum to "ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance" [Blood Cells Mol. Dis. 53, (1-2), (June-August 2014) 47-55], doi:10.1016/j.bcmd.2014.02.008. Blood Cells, Molecules, and Diseases. 2015 Dec;55(4):420. doi: 10.1016/j.bcmd.2015.08.005

@article{b1f2888ae8f34aa4ba76663c2162087a,

title = "Corrigendum to {"}ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance{"} [Blood Cells Mol. Dis. 53, (1-2), (June-August 2014) 47-55], doi:10.1016/j.bcmd.2014.02.008",

author = "Ferreira, {A. F.} and Moura, {L. G.} and I. Tojal and L. Ambr{\'o}sio and B. Pinto-Sim{\~o}es and N. Hamerschlak and Calin, {G. A.} and C. Ivan and Covas, {D. T.} and S. Kashima and Castro, {F. A.}",

year = "2015",

month = dec,

doi = "10.1016/j.bcmd.2015.08.005",

language = "English (US)",

volume = "55",

pages = "420",

journal = "Blood Cells, Molecules, and Diseases",

issn = "1079-9796",

publisher = "Academic Press Inc.",

number = "4",

}

TY - JOUR

T1 - Corrigendum to "ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance" [Blood Cells Mol. Dis. 53, (1-2), (June-August 2014) 47-55], doi:10.1016/j.bcmd.2014.02.008

AU - Ferreira, A. F.

AU - Moura, L. G.

AU - Tojal, I.

AU - Ambrósio, L.

AU - Pinto-Simões, B.

AU - Hamerschlak, N.

AU - Calin, G. A.

AU - Ivan, C.

AU - Covas, D. T.

AU - Kashima, S.

AU - Castro, F. A.

PY - 2015/12

Y1 - 2015/12

UR - http://www.scopus.com/inward/record.url?scp=84943587747&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943587747&partnerID=8YFLogxK

U2 - 10.1016/j.bcmd.2015.08.005

DO - 10.1016/j.bcmd.2015.08.005

M3 - Comment/debate

AN - SCOPUS:84943587747

SN - 1079-9796

VL - 55

SP - 420

JO - Blood Cells, Molecules, and Diseases

JF - Blood Cells, Molecules, and Diseases

IS - 4

ER -

Corrigendum to "ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance" [Blood Cells Mol. Dis. 53, (1-2), (June-August 2014) 47-55], doi:10.1016/j.bcmd.2014.02.008

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this